Stock Screener App

Frei -

Installieren

19.73

2.86% -0.58

after-market

Handel nachbörslich: 19.62 -0.11 -0.56%

Acadia Pharmaceuticals Inc (ACAD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Acadia Pharmaceuticals Inc-Aktie (ACAD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.88% 307.96	268.06	283.99	278.63	264.57
Cost Of Revenue	14.22% 28.32	24.79	26.23	21.65	20.73
Selling, General, and Administrative	6.30% 160.25	171.02	-	-	-
Costs And Expenses	0.94% 270.12	272.68	266.60	242.88	232.19
Operating Income/Loss	919.67% 37.84	-4.616	17.39	35.76	32.37
Income/Loss From Continuing Operations Before Tax	1,067% 46.47	3.981	26.32	44.59	40.21
Income Tax Expense/Benefit	4,253% 14.97	0.344	-247.25	-27.18	13.54
Net Income/Loss	766.10% 31.50	3.637	273.57	71.78	26.67
Basic Average Shares	0.64% 171.60	170.52	0.519	168.84	167.83
Diluted Average Shares	0.08% 172.85	172.71	0.763	170.65	168.68
Basic Earnings Per Share	800.00% 0.18	0.02	1.62	0.43	0.16
Diluted Earnings Per Share	800.00% 0.18	0.02	1.61	0.42	0.16

XENE

$35.34

3.18%

IDYA

$34.71

3.90%

CELC

$65.25

0.49%

TARS

$68.20

5.38%

TLX

$9.15

4.09%

VKTX

$24.40

5.54%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters